Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets

NHS England

This public procurement record has 5 releases in its history.

Award

02 Sep 2026 at 14:59

UK7 - Contract Details Notice
Award

29 Jul 2026 at 15:55

UK6 - Contract Award Notice
Tender

03 Jun 2026 at 14:19

UK4 - Tender Notice
Planning

02 Apr 2026 at 11:05

UK2 - Preliminary Market Engagement Notice
Planning

12 Mar 2026 at 15:56

UK1 - Pipeline Notice
Summary of the contracting process

NHS England procured a national pharmaceutical products framework for etravirine 200mg tablets, raltegravir 400mg tablets and ritonavir 100mg tablets (CPV 33600000). The requirement is for the supply of these medicines through NHS pharmacy purchasing points across England, covering the North East, North West, East Midlands, West Midlands, East of England, London and the South West. It is a goods procurement managed by NHS England’s medicines procurement and supply chain function. The framework is intended to support NHS purchasing of these specific antiretroviral medicines, with suppliers offering products that are, or are planned to be, brought to market during the framework period. The arrangement covers a single grouping of the three medicines.

The procurement has been awarded following an open procedure. One lot was completed, with four valid final bids, and the contract was awarded on 29 July 2026 to Merck Sharp & Dohme (UK) Limited, Orifarm UK, Unicorn Pharmaceuticals Ltd and Lupin Healthcare (UK) Limited. The awarded contract value is £8,545,000 excluding VAT and £10,254,000 including VAT. The contract was signed on 12 August 2026 and runs from 1 November 2026 to 31 October 2027, with options at NHS England’s discretion to extend for up to 24 months, to a maximum end date of 31 October 2029. The framework uses reopening competition, and the lot’s award criterion was price weighted at 100%.

This award demonstrates established NHS demand for suppliers able to manufacture, market or distribute etravirine, raltegravir and ritonavir tablets at national purchasing-point scale. The successful field included one large pharmaceutical company and three SMEs, indicating that smaller specialist suppliers can compete where they can meet the product and supply requirements. A credible future competitor would need a reliable route to market for the specified medicines, the ability to supply NHS purchasing points across England, and capacity to support a framework involving reopening competition. Suppliers would also need to satisfy NHS quality assurance and quality-control requirements, complete the procurement-specific questionnaire and provide the technical, product and commercial information required for evaluation.

How relevant is this notice?

Notice Information

Notice Title

NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets

Notice Description

Project title: NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets Offer reference number: CM/TNS/26/5745 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/26/5745 Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg Lot 1 DNE, LNW & SOFE 1 November 2026 to 31 October 2027 (12 months) Lot 2 DNW & MAE 1 November 2026 to 31 October 2027 (12 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Lot Information

Lot 1

Renewal: Option or options to extend (at the discretion of the Authority) up to a maximum of 24 months

Planning Information

NHS England is seeking to engage with current or potential new suppliers that are planning to launch any of the molecules that will be covered by this procurement. Interested suppliers will be invited to a virtual preliminary market engagement meeting. The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's. Please contact katie.noonan@nhs.net or marie.graney1@nhs.net to register your interest in tendering for this framework. Please indicate which products your company is planning to bring to market in your response.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-0668c0
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/083119-2026
Current Stage
Award
All Stages
Planning, Tender, Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£5,400,000 £1M-£10M
Lots Value
£5,400,000 £1M-£10M
Awards Value
£8,545,000 £1M-£10M
Contracts Value
£8,545,000 £1M-£10M

Notice Dates

Publication Date
2 Sep 20261 weeks ago
Submission Deadline
1 Jul 2026Expired
Future Notice Date
27 May 2026Expired
Award Date
29 Jul 20261 months ago
Contract Period
1 Nov 2026 - 31 Oct 2027 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 8UG
Postcode Area
South East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England)
Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Supplier Information

Number of Suppliers
4
Supplier Names

Merck Sharpe & Dohme (UK) Limited

Orifarm UK

UNICORN PHARMACEUTICALS LIMITED

Lupin Healthcare (UK) Limited

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...